About: Aura Biosciences, Inc., a clinical-stage biotechnology company, develops precision therapies to treat solid tumors. The company's proprietary platform enables the targeting of a range of solid tumors using virus-like particles conjugated with drugs or loaded with nucleic acids to create virus-like drug conjugates. Its lead candidate is bel-sar, which is in late-stage clinical development for the treatment of patients with primary choroidal melanoma and other ocular oncology indications, as well as in early-stage clinical development in bladder cancer. It focuses on assessing the safety and efficacy of bel-sar in treating a range of other solid tumors, including bladder cancer. The company was incorporated in 2009 and is headquartered in Boston, Massachusetts.
Sector: Healthcare
Industry: Biotechnology
Latest price: $6.27 (-4.13%)
AURA NASDAQ Aura Biosciences Inc
Aura Biosciences Inc share price
AURA price activity
Last Price
$6.270
Change (24hr)
-0.27 USD (-4.13%)
Volume
937.26K
Volume (4w avg)
-
Open
$6.53
Day Range
$6.27 - $6.53
Previous Close
$6.54
Last Trade
13 Oct, 7:06 pm GMT+0
Delayed
13 Oct, 7:06 pm GMT+0
AURA price performance
Delayed
13 Oct, 7:06 pm GMT+0
AURA Market Signals